Cartesian Therapeutics Inc.
RNAC | NASDAQ
$8.16
+$0.22 (+2.77%)
Sep 22, 2026, 2:05 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -1.44 | -5.99 | -0.40 | 4.62 | -14.51 | -4.45 |
PEG Ratio | -0.02 | 0.06 | 0 | -0.02 | 0.22 | 0.10 |
PS Ratio | 66.95 | 11.92 | 3.91 | 1.23 | 3.65 | 15.40 |
PB Ratio | -1.48 | -68.21 | -0.23 | 1.45 | 13.79 | -14.19 |
P/FCF Ratio | -2.36 | -14.16 | -1.98 | -4.15 | -5.05 | 7.50 |
P/OCF Ratio | -2.53 | -19.60 | -1.99 | -4.31 | -5.14 | 7.33 |
OCF/S Ratio | -2.64K | -60.84 | -196.74 | -28.55 | -70.97 | 210.16 |
Debt / Equity Ratio | -0.10 | -2.06 | -0.02 | 0.40 | 1.57 | -1.96 |
Quick Ratio | 8.65 | 9.43 | 1.33 | 5.91 | 2 | 1.86 |
Current Ratio | 8.65 | 9.43 | 1.33 | 5.91 | 2 | 1.86 |
Asset Turnover | 0.01 | 0.09 | 0.09 | 0.67 | 0.53 | 0.10 |
Interest Coverage | n/a | n/a | -30.50 | 4.80 | -1.62 | -36.52 |
Return on Equity | 103.22% | 1.14K% | 49.91% | 37.71% | -114.06% | 382.52% |
Return on Assets | -43.96% | -17.80% | -72.02% | 21.33% | -16.07% | -41.63% |
Return on Invested Capital | -28.36% | -10.58% | -33.28% | 9.63% | -4.86% | -67.01% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 100% | 100% | 100% | 98.16% | 100% | 100% |
Net Profit Margin | -4.66K% | -198.97% | -844.91% | 31.94% | -30.19% | -414.99% |
Pretax Profit Margin | -4.99K% | -198.23% | -917.97% | 31.39% | -11.43% | -414.99% |
Operating Profit Margin | -3.1K% | -112.81% | -332.32% | 13.12% | -5.40% | -342.36% |
FCF Margin | -2.84K% | -84.21% | -197.53% | -29.64% | -72.25% | 205.25% |
EBITDA Margin | -4.88K% | -195.27% | -903.84% | 35.96% | -6.06% | -395.21% |
Add to Watchlist
Select watchlists to add or remove RNAC